Blaine Mooers to Receptor, trkC
This is a "connection" page, showing publications Blaine Mooers has written about Receptor, trkC.
Connection Strength
0.190
-
Patient-driven discovery and post-clinical validation of NTRK3 fusion as an acquired resistance mechanism to selpercatinib in RET fusion-positive lung cancer. Ann Oncol. 2021 06; 32(6):817-819.
Score: 0.190